SOX11 variants cause a neurodevelopmental disorder with infrequent ocular malformations and hypogonadotropic hypogonadism and with distinct DNA methylation profile

No Thumbnail Available
Authors
Al-Jawahiri, R.
Foroutan, A.
Kerkhof, J.
McConkey, H.
Levy, M.
Haghshenas, S.
Rooney, K.
Turner, J.
Shears, D.
Holder, M.
Journal
Genetics in medicine
Type
Journal Article
Publisher
Nature
Rights
© 2022 American College of Medical Genetics and Genomics. Published by Elsevier Inc. All rights reserved.
PURPOSE: This study aimed to undertake a multidisciplinary characterization of the phenotype associated with SOX11 variants. METHODS: Individuals with protein altering variants in SOX11 were identified through exome and genome sequencing and international data sharing. Deep clinical phenotyping was undertaken by referring clinicians. Blood DNA methylation was assessed using Infinium MethylationEPIC array. The expression pattern of SOX11 in developing human brain was defined using RNAscope. RESULTS: We reported 38 new patients with SOX11 variants. Idiopathic hypogonadotropic hypogonadism was confirmed as a feature of SOX11 syndrome. A distinctive pattern of blood DNA methylation was identified in SOX11 syndrome, separating SOX11 syndrome from other BAFopathies. CONCLUSION: SOX11 syndrome is a distinct clinical entity with characteristic clinical features and episignature differentiating it from BAFopathies.
Citation
Genet Med. 2022 Mar 24:S1098-3600(22)00665-7. doi: 10.1016/j.gim.2022.02.013.
Note
RD&E staff can access the full-text of this article by clicking on the 'Additional Link' above and logging in with NHS OpenAthens if prompted.